Back

Sodium glucose co-transport inhibitors to treat heart failure in patients with complex adult congenital heart disease - a systematic review and meta-analysis.

2026-01-16 cardiovascular medicine Title + abstract only
View on medRxiv
Show abstract

BackgroundSodium glucose co-transport inhibitors (SGLT2i), although established heart failure (HF) therapy in acquired heart disease, are not well-studied in adult congenital heart disease (ACHD). We aimed to conduct a systematic review and meta-analysis of SGLT2i therapy in moderate or severe complexity ACHD. MethodsFive databases (Pubmed, Medline, Embase, SCOPUS, and Cochrane) were searched for peer-reviewed journal articles describing SGLT2i HF therapy in moderate or severe complexity ACHD. ...

Predicted journal destinations